Anaptysbio (ANAB) Accumulated Expenses (2016 - 2025)
Historic Accumulated Expenses for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $33.2 million.
- Anaptysbio's Accumulated Expenses fell 1361.94% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year decrease of 1361.94%. This contributed to the annual value of $39.5 million for FY2024, which is 2755.84% up from last year.
- Per Anaptysbio's latest filing, its Accumulated Expenses stood at $33.2 million for Q3 2025, which was down 1361.94% from $30.2 million recorded in Q2 2025.
- Anaptysbio's Accumulated Expenses' 5-year high stood at $39.5 million during Q4 2024, with a 5-year trough of $11.8 million in Q1 2021.
- For the 5-year period, Anaptysbio's Accumulated Expenses averaged around $25.8 million, with its median value being $30.2 million (2025).
- In the last 5 years, Anaptysbio's Accumulated Expenses crashed by 2240.48% in 2021 and then surged by 11038.65% in 2023.
- Over the past 5 years, Anaptysbio's Accumulated Expenses (Quarter) stood at $12.9 million in 2021, then skyrocketed by 68.31% to $21.6 million in 2022, then skyrocketed by 43.15% to $31.0 million in 2023, then increased by 27.56% to $39.5 million in 2024, then decreased by 16.02% to $33.2 million in 2025.
- Its Accumulated Expenses was $33.2 million in Q3 2025, compared to $30.2 million in Q2 2025 and $36.0 million in Q1 2025.